Lucid Diagnostics (LUCD) Stock Price
Lucid Diagnostics Price
Revenue has compounded at 75.2% per year over the past 4 years to 4.71 M USD. Lucid Diagnostics's net margin stands at -1,232.7%, up from -5,615.6% several years earlier. Analysts set a median price target of 2.00 USD, implying 206.4% above the current price. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.
Lucid Diagnostics stock price
Lucid Diagnostics business model & stock analysis
Frequently asked questions about Lucid Diagnostics
Analysts currently set an average price target of 2.00 USD for the Lucid Diagnostics stock (median: 2.00 USD), implying +206.4 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Lucid Diagnostics stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Lucid Diagnostics to generate revenue of 6.31 M USD and earnings per share of -0.35 USD.
Converted at the current exchange rate, the Lucid Diagnostics share trades at 0.58 EUR (0.65 USD).
The Lucid Diagnostics share (LUCD) is listed on 1 stock exchanges, including: NASDAQ (LUCD).
The expected revenue of Lucid Diagnostics is 6.31 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Lucid Diagnostics is -35.35 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Lucid Diagnostics is currently -1.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lucid Diagnostics stock.
The price-to-sales ratio (P/S) of Lucid Diagnostics is currently 10.55. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Lucid Diagnostics stock.
The Eulerpool Quality Score for Lucid Diagnostics is 3/10.
The ISIN of Lucid Diagnostics is US54948X1090. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Lucid Diagnostics is LUCD. The ticker symbol is used to trade Lucid Diagnostics shares on the stock exchange.
Lucid Diagnostics stock
Lucid Diagnostics Peer Group
Lucid Diagnostics Ticker
Lucid Diagnostics FIGI
All fundamentals and in-depth analysis of Lucid Diagnostics
Our stock analysis for Lucid Diagnostics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lucid Diagnostics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.